Evidence map›Paper›PMID 41044421›Full record

ArticleNature chemistry2025

Leveraging electron donor-acceptor complexes for kinetic resolution in catalytic asymmetric photochemical synthesis.

Tianju Shao, Zongxun Li, Feiyun Nie, Qiang Li, Xiaowei Zhao, Zhiyong Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Bifunctional Photocatalysts: Exploiting Proximity for Enhanced Reaction Performance.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tianju ShaoPingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, P. R. China.ORCID http://orcid.org/0009-0000-2167-9882
Zongxun LiPingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, P. R. China.ORCID http://orcid.org/0009-0009-7845-038X
Feiyun NiePingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, P. R. China.ORCID http://orcid.org/0009-0001-6299-7083
Qiang LiPingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, P. R. China.
Xiaowei ZhaoCollege of Pharmacy, Henan University, Kaifeng, P. R. China.
Zhiyong JiangPingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, P. R. China. jiangzhiyong@htu.edu.cn.ORCID http://orcid.org/0000-0002-6350-7429

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21925103
6 · The paper itself

Abstract

The formation of electron donor-acceptor (EDA) complexes has emerged as a powerful strategy for accessing valuable molecules. However, protocols for constructing enantio-enriched molecules are limited, typically relying on EDA complex formation between a substrate and an intermediate generated from a chiral catalyst along with another substrate. This approach facilitates the coupling of the resulting radical species, thereby enabling the controlled enantioselective formation of stereocentres. Here we introduce a kinetic resolution strategy that harnesses the formation of EDA complexes between a chiral catalyst and racemic feedstock. The key lies in the thermodynamic disparity of the chiral catalyst's interaction with the two enantiomers of the substrate, which is critical for enabling subsequent transformations under a kinetic control. We demonstrate that photochemical reactions involving racemic azaarene-functionalized tertiary alcohols and amines, together with a chiral phosphoric acid, yield enantio-enriched derivatives containing tertiary carbon stereocentres. The utility of this approach is further exemplified by synthesizing important azaarene variants featuring tertiary or secondary C-F bonds, as well as ethylene oxides.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.